This inventor holds 1 USPTO granted patent. Top assignee: Viscum Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Bernd W Muller: Innovator in Pharmaceutical Preparations
Introduction
Bernd W Muller is a notable inventor based in Flintbeck, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable medicaments. His work focuses on innovative methods for producing pharmaceutical preparations that enhance the efficacy and stability of medicinal compounds.
Latest Patents
Muller holds a patent for a "Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides." This invention relates to a method for producing a medicament that contains a polypeptide, which includes at least one recombinant carbohydrate-binding polypeptide or its functional fragments. The polypeptide is designed to be stable for storage, ensuring its effectiveness when used as a medication. The invention also describes the formulation of these medicaments into various pharmaceutical forms, enhancing their usability in medical applications. He has 1 patent to his name.
Career Highlights
Muller is associated with Viscum AG, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in the production of effective medicaments, particularly those that involve complex polypeptide structures. His career reflects a commitment to improving healthcare through innovative pharmaceutical solutions.
Collaborations
Muller has collaborated with notable colleagues, including Oliver Gloger and Klaus Witthohn. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.
Conclusion
Bernd W Muller is a distinguished inventor whose work in pharmaceutical preparations has made a significant impact on the industry. His innovative approaches to creating stable medicaments demonstrate his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile